论文部分内容阅读
根据《深化医药流通体制改革的指导意见》，在2004年年底之前，国家将扶持建立5到10个面向国内外市场、多元化经营、年销售额达到50亿元的特大型医药流通企业集团，建立40个面向国内市场或国内区域性市场、年销售额达到20亿元的大型医药流通企业集团，使其销售总额达到全国销售
According to the Guiding Opinions on Deepening the Reform of Pharmaceutical Circulation System, by the end of 2004, the state will support the establishment of 5 to 10 large pharmaceutical distribution conglomerates that are oriented to the domestic and foreign markets and are diversified and have annual sales of 5 billion yuan. Establish 40 large-scale pharmaceutical circulation enterprise groups facing the domestic market or domestic regional market with annual sales volume of 2 billion yuan to make the total sales reach the national sales